...
首页> 外文期刊>Journal of Korean medical science >The model for end-stage liver disease score-based system predicts short term mortality better than the current child-turcotte-pugh score-based allocation system during waiting for deceased liver transplantation
【24h】

The model for end-stage liver disease score-based system predicts short term mortality better than the current child-turcotte-pugh score-based allocation system during waiting for deceased liver transplantation

机译:基于终末肝病评分系统的模型预测在等待已故肝移植期间的短期死亡率要优于当前基于儿童-turcotte-pugh评分系统的分配系统

获取原文
获取原文并翻译 | 示例
           

摘要

To adopt the model for end-stage liver disease (MELD) score-based system in Korea, the feasibility should be evaluated by analysis of Korean database. The aim of this study was to investigate the feasibility of the MELD score-based system compared with the current Child-Turcotte-Pugh (CTP) based-system and to suggest adequate cut-off to stratify waiting list mortality among Korean population. We included 788 adult patients listed in waiting list in Seoul National University Hospital from January 2008 to May 2011. The short-term survival until 6 months after registration was evaluated. Two hundred forty six (31.2%) patients underwent live donor liver transplantation and 353 (44.8%) patients were still waiting and 121 (15.4%) patients were dropped out due to death. Significant difference was observed when MELD score 24 and 31 were used as cut-off. Three-months survival of Status 2A was 70.2%. However, in Status 2A patients whose MELD score less than 24 (n= 82), 86.6% of patients survived until 6month. Furthermore, patients with high MELD score (≥ 31) among Status 2B group showed poorer survival rate (45.8%, 3-month) than Status 2A group. In conclusion, MELD score-based system can predict short term mortality better and select more number of high risk patients in Korean population.
机译:为了在韩国采用基于终末期肝病(MELD)评分的系统模型,应通过分析韩国数据库评估可行性。这项研究的目的是调查与当前的基于Child-Turcotte-Pugh(CTP)的系统相比,基于MELD评分的系统的可行性,并提出适当的分界值,以对韩国人群中的等候名单死亡率进行分层。我们纳入了2008年1月至2011年5月在首尔国立大学医院候诊名单中列出的788名成年患者。评估了注册后6个月内的短期生存率。 246例(31.2%)患者接受了活体肝移植手术,其中353例(44.8%)仍在等待中,另有121例(15.4%)因死亡而退学。当MELD评分24和31用作临界值时,观察到显着差异。状态2A的三个月生存率为70.2%。但是,在状态2A的患者中,MELD得分低于24(n = 82)的患者中,有86.6%的患者存活到6个月。此外,状态2B组中MELD评分较高(≥31)的患者的生存率(状态3B为45.8%,3个月)较状态2A组低。总之,基于MELD评分的系统可以更好地预测短期死亡率,并选择更多数量的韩国高危患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号